Therefore, we concluded that upregulated ANGPTL1/2/4 were correlated with poor prognosis in GC patients based on data from LinkedOmics and Kaplan–Meier Plotter [Figure 6]. This evidence concerns the gene ANGPTL1 and gastric cancer.